Article ; Online: Extracorporeal Membrane Oxygenation Support as a Bridge to Recovery during Chemotherapy in a Young Patient with Metastatic Choriocarcinoma and Severe Acute Respiratory Distress Syndrome.
Oncology research and treatment
2020 Volume 43, Issue 10, Page(s) 559–564
Abstract: Introduction: A young woman presented at a local hospital with severe dyspnea directly after childbirth. She was di-agnosed with choriocarcinoma and massive pulmonary metastases. Shortly after administration of polychemotherapy she developed severe ... ...
| Abstract | Introduction: A young woman presented at a local hospital with severe dyspnea directly after childbirth. She was di-agnosed with choriocarcinoma and massive pulmonary metastases. Shortly after administration of polychemotherapy she developed severe acute respiratory distress syndrome (ARDS). Case presentation: The patient was transferred to the intensive care unit (ICU) and extracorporeal membrane oxygenation (ECMO) center of the university hospital. Venovenous ECMO support was implemented for 28 days while enabling continuous chemotherapy. After 49 days in the ICU, she was transferred to the oncology ward in a stable respiratory state. Discussion/conclusion: Although the survival rates of ARDS in the general ICU population have improved lately due to improved management of ARDS and ECMO support, the data on adult cancer patients receiving ECMO support are very limited. Only few small retrospective studies on ECMO support in adult cancer patients have been conducted. Unfortunately the survival rates of patients after allogenic hematopoietic stem cell transplantation and ECMO support were discouraging. Nevertheless, cancer patients with at least stable disease who are eligible for full-code ICU management may be potential candidates for ECMO in case of severe ARDS. Our case report not only shows that patients suffering from choriocarcinoma with pulmonary metastases may develop severe ARDS in the context of polychemotherapy, but also demonstrates that ECMO support enables chemotherapy continuation and complete remission of the underlying choriocarcinoma. |
|---|---|
| MeSH term(s) | Adult ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Choriocarcinoma/secondary ; Choriocarcinoma/therapy ; Extracorporeal Membrane Oxygenation/methods ; Female ; Hematopoietic Stem Cell Transplantation ; Humans ; Intensive Care Units ; Lung Neoplasms/secondary ; Lung Neoplasms/therapy ; Pregnancy ; Respiratory Distress Syndrome/chemically induced ; Respiratory Distress Syndrome/therapy ; Retrospective Studies ; Treatment Outcome ; Uterine Neoplasms/pathology ; Uterine Neoplasms/therapy |
| Chemical Substances | Antineoplastic Agents |
| Language | English |
| Publishing date | 2020-08-18 |
| Publishing country | Netherlands |
| Document type | Case Reports |
| ZDB-ID | 2760274-6 |
| ISSN | 2296-5262 ; 2296-5270 |
| ISSN (online) | 2296-5262 |
| ISSN | 2296-5270 |
| DOI | 10.1159/000509428 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 1414: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.